Bard Proposes Ventralight ST & Ventralex Claims For Initial Trials
Bard Proposes Ventralight ST & Ventralex Claims For Initial Trials

Introduction
C.R. Bard and its Davol, Inc. subsidiary have proposed that from over a thousand lawsuits faced by them, claims related to Bard Ventralight ST and Bard Ventralex mesh be the first to go before a jury later this year.
The company faces more than 3,500 lawsuits with similar allegations from plaintiffs due to various hernia polypropylene mesh device, namely Ventralex, Ventralight, PerFix, 3DMax, and other devices. The outcomes of these trials will not be forced on other pending lawsuits. U.S. District Judge Edmund A. Sargus in the Southern District of Ohio will look into the proceedings of the trials which are scheduled to begin on May 11, 2020; July 13, 2020; and September 14, 2020.
Bard has proposed to start the trials with Ventralight ST and Ventralex, as the lawsuits involving these devices are more as compared to other devices, which will ease the process of determining the potential settlement.
Latest News
Talcum Powder Cancer Settlement Talks Begin Sept. 4
Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…
Tepezza Hearing Loss Trials Delayed Until Aug 2026
A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…
Cencora Directors Settle Opioid Oversight Case for $111M
Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids…